IN BRIEF: Avacta Appoints BBI Solutions To Manufacture Covid Test Kit
IN BRIEF: Avacta Appoints BBI Solutions To Manufacture Covid Test Kit
Read moreThu, 22nd Sep 2016 15:56
IN BRIEF: Avacta Appoints BBI Solutions To Manufacture Covid Test Kit
Read more(Sharecast News) - Biotechnology company Avacta on Thursday appointed BBI Solutions as a manufacturing partner for the development of its rapid SARS-CoV-2 antigen test.
Read moreIN BRIEF: Avacta Expands Partnership With Daewoong Pharmaceutical
Read more(Sharecast News) - Biotherapeutics and reagents developer Avacta Group announced an expansion of its collaboration and license agreement with Daewoong Pharmaceutical and AffyXell Therapeutics - the joint venture established in South Korea by the two companies - to develop stem cell treatments on Wednesday.
Read moreUK TRADING UPDATE SUMMARY: Virus Hits Mears But Tristel Gets Boost
Read more(Sharecast News) - Avacta Group has started work with the UK government's 'CONDOR' programme, it announced on Wednesday, to evaluate and clinically validate the high throughput Covid-19 bead-assisted mass spectrometry laboratory assay, developed with Adeptrix.
Read moreAvacta Partners With Integumen To Detect Covid-19 In Waste Water
Read more(Sharecast News) - Biotherapeutics company Avacta Group has entered into a collaboration with its AIM peer Integumen, it announced on Monday, to evaluate recently-generated Affimer reagents that bind the SARS-CoV-2 spike protein for the detection of the coronavirus in wastewater, to provide a real-time alert system to warn of localised Covid-19 outbreaks.
Read moreIN BRIEF: Avacta Posts Positive Results For Covid-19 Detection Test
Read more(Sharecast News) - Avacta Group announced on Wednesday that the first 'Affimer'-based rapid test strips to detect SARS-CoV-2 (Covid-19) spike protein had been developed and evaluated by its partners at Cytiva - formerly GE Healthcare Life Sciences - and reportedly showed positive initial performance data.
Read moreLONDON, June 22 (Reuters) - A weekly coronavirus testing regime using a "no-swab" saliva test is being trialled in Southampton, southern England, and could result in a simpler and quicker way to detect outbreaks of the virus, the British governme...
Read more(Sharecast News) - Avacta Group announced on Thursday that collaborative work with the Centre for Virus Research at the University of Glasgow has shown that its 'Affimer' reagents, which bind to the SARS-COV-2 (Covid-19) virus spike protein, prevent infection of human cells by a SARS-COV-2 model virus, and therefore provide a potential therapy for Covid-19 infection.
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test
Read more(Sharecast News) - Avacta said its Covid-19 antigen test had reached prototype stage and could detect the virus in model samples.
Read more